SK13562002A3 - Antiseptický obklad - Google Patents
Antiseptický obklad Download PDFInfo
- Publication number
- SK13562002A3 SK13562002A3 SK1356-2002A SK13562002A SK13562002A3 SK 13562002 A3 SK13562002 A3 SK 13562002A3 SK 13562002 A SK13562002 A SK 13562002A SK 13562002 A3 SK13562002 A3 SK 13562002A3
- Authority
- SK
- Slovakia
- Prior art keywords
- elastomeric matrix
- surfactant
- wound
- dressing
- antiseptic
- Prior art date
Links
- 230000002421 anti-septic effect Effects 0.000 title abstract description 12
- 239000004094 surface-active agent Substances 0.000 claims abstract description 20
- 239000004599 antimicrobial Substances 0.000 claims abstract description 18
- 239000000416 hydrocolloid Substances 0.000 claims abstract description 18
- 239000011159 matrix material Substances 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims description 18
- 239000011248 coating agent Substances 0.000 claims description 15
- 238000000576 coating method Methods 0.000 claims description 15
- 239000003921 oil Substances 0.000 claims description 13
- 238000005253 cladding Methods 0.000 claims description 9
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000004264 Petrolatum Substances 0.000 claims description 7
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 7
- 229940066842 petrolatum Drugs 0.000 claims description 7
- 235000019271 petrolatum Nutrition 0.000 claims description 7
- -1 polyethylene-butylene Polymers 0.000 claims description 7
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 6
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 6
- 239000004793 Polystyrene Substances 0.000 claims description 4
- 229920002223 polystyrene Polymers 0.000 claims description 4
- 229920001935 styrene-ethylene-butadiene-styrene Polymers 0.000 claims description 4
- 229920003051 synthetic elastomer Polymers 0.000 claims description 4
- FBPFZTCFMRRESA-NQAPHZHOSA-N Sorbitol Polymers OCC(O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-NQAPHZHOSA-N 0.000 claims description 3
- 229920001400 block copolymer Polymers 0.000 claims description 3
- 239000000835 fiber Substances 0.000 claims description 3
- 239000002736 nonionic surfactant Substances 0.000 claims description 3
- 229920002742 polystyrene-block-poly(ethylene/propylene) -block-polystyrene Polymers 0.000 claims description 3
- 229920006395 saturated elastomer Polymers 0.000 claims description 3
- 229920001577 copolymer Polymers 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 2
- 239000000194 fatty acid Substances 0.000 claims description 2
- 229930195729 fatty acid Natural products 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000012188 paraffin wax Substances 0.000 claims description 2
- 238000004026 adhesive bonding Methods 0.000 claims 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical group [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims 1
- 239000004519 grease Substances 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 description 15
- 208000027418 Wounds and injury Diseases 0.000 description 15
- 239000000499 gel Substances 0.000 description 14
- 239000002250 absorbent Substances 0.000 description 11
- 239000004744 fabric Substances 0.000 description 11
- 230000002745 absorbent Effects 0.000 description 10
- 239000013543 active substance Substances 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 10
- 230000001070 adhesive effect Effects 0.000 description 10
- 230000001580 bacterial effect Effects 0.000 description 10
- 229920001971 elastomer Polymers 0.000 description 10
- 239000000806 elastomer Substances 0.000 description 10
- 208000015181 infectious disease Diseases 0.000 description 6
- SEEPANYCNGTZFQ-UHFFFAOYSA-N sulfadiazine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)NC1=NC=CC=N1 SEEPANYCNGTZFQ-UHFFFAOYSA-N 0.000 description 6
- 229960004306 sulfadiazine Drugs 0.000 description 6
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 229910001118 argentium sterling silver Inorganic materials 0.000 description 5
- 239000006185 dispersion Substances 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 241000765083 Ondina Species 0.000 description 3
- 239000005662 Paraffin oil Substances 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000000845 anti-microbial effect Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- IHCDKJZZFOUARO-UHFFFAOYSA-M sulfacetamide sodium Chemical compound O.[Na+].CC(=O)[N-]S(=O)(=O)C1=CC=C(N)C=C1 IHCDKJZZFOUARO-UHFFFAOYSA-M 0.000 description 3
- 229920002633 Kraton (polymer) Polymers 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000012943 hotmelt Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical class CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 241000722985 Fidia Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003123 carboxymethyl cellulose sodium Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229940063834 carboxymethylcellulose sodium Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000001033 granulometry Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229960001915 hexamidine Drugs 0.000 description 1
- OQLKNTOKMBVBKV-UHFFFAOYSA-N hexamidine Chemical compound C1=CC(C(=N)N)=CC=C1OCCCCCCOC1=CC=C(C(N)=N)C=C1 OQLKNTOKMBVBKV-UHFFFAOYSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 230000000887 hydrating effect Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000002530 phenolic antioxidant Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 150000003378 silver Chemical class 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000010388 wound contraction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/48—Surfactants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0003665A FR2806629B1 (fr) | 2000-03-22 | 2000-03-22 | Compresse antiseptique |
| PCT/FR2001/000834 WO2001070285A1 (fr) | 2000-03-22 | 2001-03-21 | Compresse antiseptique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SK13562002A3 true SK13562002A3 (sk) | 2003-02-04 |
Family
ID=8848384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1356-2002A SK13562002A3 (sk) | 2000-03-22 | 2001-03-21 | Antiseptický obklad |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6794555B2 (ja) |
| EP (1) | EP1272229B1 (ja) |
| JP (1) | JP4708658B2 (ja) |
| CN (1) | CN1204929C (ja) |
| AT (1) | ATE254484T1 (ja) |
| AU (1) | AU4428301A (ja) |
| BG (1) | BG107128A (ja) |
| CA (1) | CA2402640C (ja) |
| CZ (1) | CZ20023172A3 (ja) |
| DE (1) | DE60101269T2 (ja) |
| DK (1) | DK1272229T3 (ja) |
| EE (1) | EE200200533A (ja) |
| ES (1) | ES2211788T3 (ja) |
| FR (1) | FR2806629B1 (ja) |
| HK (1) | HK1052307A1 (ja) |
| HU (1) | HUP0300269A2 (ja) |
| MX (1) | MXPA02009315A (ja) |
| NO (1) | NO20024515L (ja) |
| PL (1) | PL357215A1 (ja) |
| PT (1) | PT1272229E (ja) |
| SK (1) | SK13562002A3 (ja) |
| TN (1) | TNSN01043A1 (ja) |
| WO (1) | WO2001070285A1 (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2373069B (en) * | 2001-03-05 | 2005-03-23 | Ibm | Method, apparatus and computer program product for integrating heterogeneous systems |
| GB0225761D0 (en) * | 2002-11-05 | 2002-12-11 | Univ Bradford | Polymeric materials |
| DE102005060461A1 (de) | 2005-12-17 | 2007-07-12 | Paul Hartmann Ag | Medizinische Zusammensetzung |
| GB2439525A (en) * | 2006-06-28 | 2008-01-02 | Mid Essex Hospital Services Nh | Dressing for treating burns |
| US8026407B2 (en) * | 2006-08-01 | 2011-09-27 | 3M Innovative Properties Company | Antimicrobial compression bandage |
| FR2916355B1 (fr) * | 2007-05-25 | 2009-08-28 | Urgo Soc Par Actions Simplifie | Nouveau principe actif dans la cicatrisation et son utilisation |
| FR2916356B1 (fr) | 2007-05-25 | 2009-08-28 | Urgo Soc Par Actions Simplifie | Nouvel agent permettant le relargage d'actifs dans des pansements contenant au moins un corps gras |
| FR2936158A1 (fr) * | 2008-09-24 | 2010-03-26 | Plasto | Interface chirurgicale pour plaie, sans support |
| FR2936159B1 (fr) * | 2008-09-24 | 2010-10-22 | Plasto | Interface chirurgicale pour plaie, avec support |
| GB0821345D0 (en) * | 2008-11-21 | 2008-12-31 | P Q Silicas Uk Ltd | Composition and dressing with nitric oxide |
| EP2558132B1 (en) | 2010-04-14 | 2020-10-14 | Mölnlycke Health Care AB | Antimicrobial gels |
| US8846740B2 (en) | 2011-01-04 | 2014-09-30 | Biological Responsibility, Llc | Biotherapeutics for the treatment of infectious diseases |
| FR2993464B1 (fr) * | 2012-07-17 | 2014-08-22 | Urgo Lab | Pansement interface autoporte |
| FR3050937B1 (fr) * | 2016-05-04 | 2018-05-25 | Urgo Recherche Innovation Et Developpement | Composition optimisee pour pansement interface |
| FR3066390B1 (fr) | 2017-05-17 | 2019-07-12 | Urgo Recherche Innovation Et Developpement | Utilisation de composes oligosaccharidiques pour traiter les plaies des patients diabetiques arteriopatiques |
| FR3068974B1 (fr) * | 2017-07-12 | 2019-08-02 | Urgo Recherche Innovation Et Developpement | Pansement permettant la liberation controlee et prolongee d'actif |
| US20210361820A1 (en) * | 2018-01-31 | 2021-11-25 | Systagenix Wound Management, Limited | Antimicrobial composition, dressing, dressing components, and method |
| TWI694844B (zh) | 2019-01-29 | 2020-06-01 | 明基材料股份有限公司 | 硫化氫緩釋敷料及其製造方法 |
| CN109793919B (zh) * | 2019-02-01 | 2022-01-14 | 明基材料（芜湖）有限公司 | 硫化氢缓释敷料及其制造方法 |
| FR3113583A1 (fr) | 2020-08-26 | 2022-03-04 | Urgo Recherche Innovation Et Developpement | Utilisation de composes oligosaccharidiques pour augmenter l’oxygenation de la peau lors du traitement des plaies ischemiques |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1599159A (en) * | 1977-02-08 | 1981-09-30 | Roussel Lab Ltd | Pharmaceutical compositions containing chlorhexidine |
| JPS54101420A (en) * | 1978-01-25 | 1979-08-10 | Nitto Electric Ind Co Ltd | Poultice and its preparation |
| GB2098074B (en) * | 1981-05-09 | 1984-11-07 | Smith & Nephew Associated Cie | Dressing |
| HU200103B (en) * | 1987-04-01 | 1990-04-28 | Biogal Gyogyszergyar | Process for producing pharmaceutical compositions for treating lack of epithelium |
| US5670169A (en) | 1993-12-20 | 1997-09-23 | E.R. Squibb & Sons, Inc. | Wound hydrating gel with novel preservative system and low cytotoxicity |
| FR2753380B1 (fr) * | 1996-09-16 | 1998-12-04 | Lhd Lab Hygiene Dietetique | Nouvelle masse adhesive hydrophile |
| US6039940A (en) * | 1996-10-28 | 2000-03-21 | Ballard Medical Products | Inherently antimicrobial quaternary amine hydrogel wound dressings |
| FR2775903B1 (fr) * | 1998-03-12 | 2001-06-08 | Lhd Lab Hygiene Dietetique | Masse hydrocolloide a absorption accrue des les premieres heures d'utilisation |
| US20020147265A1 (en) * | 2001-01-19 | 2002-10-10 | Scapa North America | Hydrocolloid compositions |
| US20030175333A1 (en) * | 2002-03-06 | 2003-09-18 | Adi Shefer | Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin |
-
2000
- 2000-03-22 FR FR0003665A patent/FR2806629B1/fr not_active Expired - Lifetime
-
2001
- 2001-03-19 TN TNTNSN01043A patent/TNSN01043A1/fr unknown
- 2001-03-21 CZ CZ20023172A patent/CZ20023172A3/cs unknown
- 2001-03-21 EE EEP200200533A patent/EE200200533A/xx unknown
- 2001-03-21 PT PT01917194T patent/PT1272229E/pt unknown
- 2001-03-21 AT AT01917194T patent/ATE254484T1/de active
- 2001-03-21 PL PL01357215A patent/PL357215A1/xx not_active Application Discontinuation
- 2001-03-21 MX MXPA02009315A patent/MXPA02009315A/es active IP Right Grant
- 2001-03-21 AU AU44283/01A patent/AU4428301A/en not_active Abandoned
- 2001-03-21 WO PCT/FR2001/000834 patent/WO2001070285A1/fr active IP Right Grant
- 2001-03-21 US US10/239,125 patent/US6794555B2/en not_active Expired - Lifetime
- 2001-03-21 CN CNB018068383A patent/CN1204929C/zh not_active Expired - Lifetime
- 2001-03-21 EP EP01917194A patent/EP1272229B1/fr not_active Expired - Lifetime
- 2001-03-21 SK SK1356-2002A patent/SK13562002A3/sk unknown
- 2001-03-21 HU HU0300269A patent/HUP0300269A2/hu unknown
- 2001-03-21 JP JP2001568479A patent/JP4708658B2/ja not_active Expired - Lifetime
- 2001-03-21 CA CA002402640A patent/CA2402640C/fr not_active Expired - Lifetime
- 2001-03-21 ES ES01917194T patent/ES2211788T3/es not_active Expired - Lifetime
- 2001-03-21 DK DK01917194T patent/DK1272229T3/da active
- 2001-03-21 DE DE60101269T patent/DE60101269T2/de not_active Expired - Lifetime
-
2002
- 2002-09-20 NO NO20024515A patent/NO20024515L/no not_active Application Discontinuation
- 2002-09-20 BG BG107128A patent/BG107128A/xx unknown
-
2003
- 2003-06-12 HK HK03104198A patent/HK1052307A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1204929C (zh) | 2005-06-08 |
| NO20024515D0 (no) | 2002-09-20 |
| MXPA02009315A (es) | 2004-09-06 |
| ATE254484T1 (de) | 2003-12-15 |
| CA2402640A1 (fr) | 2001-09-27 |
| FR2806629B1 (fr) | 2003-01-24 |
| US20030036717A1 (en) | 2003-02-20 |
| EE200200533A (et) | 2004-04-15 |
| NO20024515L (no) | 2002-11-14 |
| CA2402640C (fr) | 2007-09-11 |
| EP1272229A1 (fr) | 2003-01-08 |
| DK1272229T3 (da) | 2004-03-08 |
| EP1272229B1 (fr) | 2003-11-19 |
| PL357215A1 (en) | 2004-07-26 |
| DE60101269T2 (de) | 2004-09-16 |
| PT1272229E (pt) | 2004-05-31 |
| HK1052307A1 (en) | 2003-09-11 |
| WO2001070285A1 (fr) | 2001-09-27 |
| DE60101269D1 (de) | 2003-12-24 |
| TNSN01043A1 (fr) | 2005-11-10 |
| JP4708658B2 (ja) | 2011-06-22 |
| US6794555B2 (en) | 2004-09-21 |
| AU4428301A (en) | 2001-10-03 |
| CN1418114A (zh) | 2003-05-14 |
| CZ20023172A3 (cs) | 2003-02-12 |
| HUP0300269A2 (en) | 2003-07-28 |
| BG107128A (en) | 2003-06-30 |
| FR2806629A1 (fr) | 2001-09-28 |
| ES2211788T3 (es) | 2004-07-16 |
| JP2003527212A (ja) | 2003-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SK13562002A3 (sk) | Antiseptický obklad | |
| RU2508127C2 (ru) | Покрытие для ран ii | |
| JP4902887B2 (ja) | 抗菌創傷接触層 | |
| JP6433436B2 (ja) | 改善された性質を有する抗菌性接着剤 | |
| DE60126506T2 (de) | Verbände zur behandlung von exsudierenden wunden | |
| DE69925510T2 (de) | Sterile, nichtklebende kompresse | |
| RU2093190C1 (ru) | Перевязочный материал | |
| EP1159972A2 (en) | Anti-microbial dressing using metallic compounds | |
| JPH0233261B2 (ja) | ||
| US20060211972A1 (en) | Wound dressing | |
| BRPI0708204A2 (pt) | curativo absorvente de espuma de poliuretano | |
| US20150174285A1 (en) | Self-supporting interface dressing | |
| AU2013255442B2 (en) | Wound dressings | |
| US20070020318A1 (en) | Hydrocolloid materials for use in wound healing | |
| EP1601388A1 (en) | Hydrocolloid materials for use in wound healing | |
| US20090149792A1 (en) | Composition for wound management | |
| KR20000063990A (ko) | 일회용 반창고 | |
| CZ2001912A3 (cs) | Sterilní nepřilnavý obklad |